Release Date: 30/01/12 16:56 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 388.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%